ARID1A mutations in pancreatic adenocarcinoma had one of the strongest interactions with localised mutational enrichment (interaction P = 5.0 × 10− 4) (Fig. 5b). The gene discussed is ARID1A; the disease is pancreatic adenocarcinoma.